Entity Central Index Key Cover [Abstract] Document Information [Table] Document Information [Table] Entity Addresses, Address Type Entity Addresses Address Type [Axis] Address Type Address Type [Domain] Former Address [Member] Former Address [Member] Document Information [Line Items] Document Information [Line Items] Document Type Document Type Amendment Flag Amendment Flag Current Fiscal Year End Date Current Fiscal Year End Date Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Entity Shell Company Entity Shell Company Entity Current Reporting Status Entity Current Reporting Status Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Entity Interactive Data Current Entity Interactive Data Current Title of 12(b) Security Security12b Title Security Exchange Name Security Exchange Name Entity Incorporation, State or Country Code Entity Incorporation State Country Code Document Quarterly Report Document Quarterly Report Document Transition Report Document Transition Report Statement Of Financial Position [Abstract] Assets Assets [Abstract] Current assets: Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Prepaid research and development contracts Prepaid Expense Current Other current assets Other Assets Current Total current assets Assets Current Furniture and equipment, net Property Plant And Equipment Net Operating lease right-of-use assets, net Operating Lease Right Of Use Asset Deposits Deposits Assets Noncurrent Total assets Assets Liabilities and stockholders’ equity Liabilities And Stockholders Equity [Abstract] Current liabilities: Liabilities Current [Abstract] Accounts payable and accrued expenses Accounts Payable And Accrued Liabilities Current Current portion of operating lease liability Operating Lease Liability Current Total current liabilities Liabilities Current Total liabilities Liabilities Commitments and contingencies (Note 12) Commitments And Contingencies Stockholders’ equity: Stockholders Equity [Abstract] Common stock, $0.0001 par value per share; 300,000,000 shares authorized and 47,477,084 and 47,251,319 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively. Common Stock Value Additional paid-in capital Additional Paid In Capital Common Stock Accumulated deficit Retained Earnings Accumulated Deficit Total stockholders’ equity Stockholders Equity Total liabilities and stockholders’ equity Liabilities And Stockholders Equity Common stock, par value Common Stock Par Or Stated Value Per Share Common stock, shares authorized Common Stock Shares Authorized Common stock, shares issued Common Stock Shares Issued Common stock, shares outstanding Common Stock Shares Outstanding Grant income. Income Statement [Abstract] License revenue Revenue From Contract With Customer Excluding Assessed Tax Revenue, Product and Service [Extensible Enumeration] Type Of Revenue Extensible List Operating expenses Operating Expenses [Abstract] Research and development Research And Development Expense General and administrative General And Administrative Expense Restructuring expense Restructuring Costs Total operating expenses Operating Expenses (Loss) income from operations Operating Income Loss Other income Other Nonoperating Income Grant income Grant Income Interest income Interest Income Expense Nonoperating Net Total other income Nonoperating Income Expense Net and comprehensive (loss) income Net Income Loss Net and comprehensive (loss) income per common share Earnings Per Share [Abstract] Basic and diluted Earnings Per Share Basic And Diluted Weighted average number of common shares used in computing net (loss) income per share attributable to common stockholders Weighted Average Number Of Shares Outstanding [Abstract] Basic Weighted Average Number Of Shares Outstanding Basic Diluted Weighted Average Number Of Diluted Shares Outstanding Stock issued during period shares warrant exercised. Stock issued during period value warrant exercised. Statement Of Stockholders Equity [Abstract] Statement [Table] Statement [Table] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock [Member] Common Stock [Member] Additional Paid-In Capital [Member] Additional Paid In Capital [Member] Accumulated Deficit [Member] Retained Earnings [Member] Statement [Line Items] Statement [Line Items] Balance Balance, Shares Shares Outstanding Issuance of warrants Adjustments To Additional Paid In Capital Warrant Issued Issuance of common stock upon exercise of stock options Stock Issued During Period Value Stock Options Exercised Issuance of common stock upon exercise of stock options, shares Stock Issued During Period Shares Stock Options Exercised Issuance of common stock upon exercise of warrants Stock Issued During Period Value Warrant Exercised Issuance of common stock upon exercise of warrants, shares Stock Issued During Period Shares Warrant Exercised Issuance of common stock Stock Issued During Period Value New Issues Issuance of common stock, shares Stock Issued During Period Shares New Issues Stock-based compensation expense Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Net and comprehensive loss Balance Balance, Shares Consulting expenses related to warrants. Increase decrease in prepaid research and development contracts. Statement Of Cash Flows [Abstract] Operating activities: Net Cash Provided By Used In Operating Activities [Abstract] Net and comprehensive (loss) income Adjustments to reconcile net and comprehensive (loss) income to net cash used in operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Depreciation Depreciation Loss on disposal of assets Gain Loss On Disposition Of Assets1 Stock-based compensation Share Based Compensation Consulting expenses related to warrants Consulting Expenses Related To Warrants Changes in operating assets and liabilities: Increase Decrease In Operating Capital [Abstract] Prepaid research and development contracts Increase Decrease In Prepaid Research And Development Contracts Other current assets Increase Decrease In Other Current Assets Accounts payable and accrued expenses Increase Decrease In Accounts Payable And Accrued Liabilities Net cash (used in) provided by operating activities Net Cash Provided By Used In Operating Activities Investing activities: Net Cash Provided By Used In Investing Activities [Abstract] Purchase of furniture and equipment Payments To Acquire Property Plant And Equipment Net cash used in investing activities Net Cash Provided By Used In Investing Activities Financing activities: Net Cash Provided By Used In Financing Activities [Abstract] Proceeds from issuance of common stock upon exercise of stock options Proceeds From Stock Options Exercised Proceeds from issuance of common stock upon exercise of warrants Proceeds From Warrant Exercises Net cash provided by financing activities Net Cash Provided By Used In Financing Activities Net (decrease) increase in cash and cash equivalents Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Cash and cash equivalents at beginning of year Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations Cash and cash equivalents, six months ended Organization Consolidation And Presentation Of Financial Statements [Abstract] Nature of Organization and Operations Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block] Accounting Policies [Abstract] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Payables And Accruals [Abstract] Accounts Payable and Accrued Expenses Accounts Payable And Accrued Liabilities Disclosure [Text Block] The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to common stock. Preferred Stock and Common Stock [Abstract] Common Stock Common Stock [Text Block] Equity [Abstract] Preferred Stock Preferred Stock [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Stock-Based Compensation Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Net and Comprehensive (Loss) Income Per Share Attributable to Common Stockholders Earnings Per Share [Text Block] Disclosure of employee stock purchase plan. Employee Stock Purchase Plan Disclosure Of Employee Stock Purchase Plan [Text Block] License agreement. Revenue From Contract With Customer [Abstract] License Agreement License Agreement [Text Block] Restructuring And Related Activities [Abstract] Restructuring Restructuring And Related Activities Disclosure [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Basis of Presentation Basis Of Accounting Policy Policy [Text Block] Segment Information Segment Reporting Policy Policy [Text Block] Use of Estimates Use Of Estimates Cash and Cash Equivalents Cash And Cash Equivalents Policy [Text Block] Revenue Recognition Revenue From Contract With Customer Policy [Text Block] Other nonoperating income expense. Other Income Other Nonoperating Income Expense Policy [Text Block] Grant income. Grant Income Grant Income Policy [Text Block] Research and Development Research And Development Expense Policy Patents Intangible Assets Finite Lived Policy Costs Incurred To Renew Or Extend Income Taxes Income Tax Policy [Text Block] Net and Comprehensive (Loss) Income per Share Attributable to Common Stockholders Earnings Per Share Policy [Text Block] Stock-Based Compensation Share Based Compensation Option And Incentive Plans Policy Fair Value of Financial Instruments Fair Value Of Financial Instruments Policy Concentrations of Credit Risk and Off-Balance Sheet Risk Concentration Risk Credit Risk Comprehensive (Loss) Income Comprehensive Income Policy Policy [Text Block] Furniture and Equipment Property Plant And Equipment Policy [Text Block] Leases Lessee Leases Policy [Text Block] Recent Accounting Pronouncements New Accounting Pronouncements Policy Policy [Text Block] Schedule of Assets Measured on Recurring Basis Fair Value Assets Measured On Recurring Basis [Text Block] Schedule of Accounts Payable and Accrued Expenses Schedule Of Accounts Payable And Accrued Liabilities Table [Text Block] Summary of Stock Option Activity Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Summary of Recognized Compensation Cost Related to Employee and Non-employee Stock-Based Compensation Activity Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Stock Options Valuation Assumptions Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block] Schedule of Computation of Basic and Diluted Net and Comprehensive (Loss) Income per Share Schedule Of Earnings Per Share Basic And Diluted Table [Text Block] Schedule of Weighted Average Common Stock Equivalents Excluded from Calculation of Basic and Diluted Net and Comprehensive (Loss) Income per Share Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Organization consolidation and presentation of financial statements line items. Organization consolidation and presentation of financial statements table Organization Consolidation And Presentation Of Financial Statements [Table] Organization Consolidation And Presentation Of Financial Statements [Table] Business Acquisition Business Acquisition [Axis] Business Acquisition, Acquiree Business Acquisition Acquiree [Domain] Merger agreement. Merger Agreement [Member] Merger Agreement [Member] Collaborative Arrangement and Arrangement Other than Collaborative Type Of Arrangement [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Arrangements And Nonarrangement Transactions [Member] Subscription agreements. Subscription Agreements [Member] Subscription Agreements [Member] Sale of Stock Subsidiary Sale Of Stock [Axis] Sale of Stock Sale Of Stock Name Of Transaction [Domain] Private Investment in Public Equity [Member] Private Placement [Member] Statistical Measurement Range [Axis] Statistical Measurement Range [Member] Maximum [Member] Maximum [Member] Minimum [Member] Minimum [Member] Ownership Ownership [Axis] Ownership Ownership [Domain] Current shareholders of Aadi Bioscience Incorporation. Current Shareholders of Aadi [Member] Current Shareholders Of Aadi Bioscience Incorporation [Member] Current shareholders. Current Shareholders of Aerpio [Member] Current Shareholders [Member] Former shareholders of Aadi Bioscience Incorporation. Former Shareholders of Aadi [Member] Former Shareholders Of Aadi Bioscience Incorporation [Member] Shareholders immediately prior to closing of merger. Company Shareholders (immediately prior to closing of the Merger) [Member] Shareholders Immediately Prior To Closing Of Merger [Member] Private investment in public equity investors. PIPE Investors [Member] Private Investment In Public Equity Investors [Member] Organization Consolidation And Presentation Of Financial Statements [Line Items] Organization Consolidation And Presentation Of Financial Statements [Line Items] Date of acquisition agreement Business Acquisition Date Of Acquisition Agreement1 Aggregate proceeds from issuance of common stock Proceeds From Issuance Of Common Stock Threshold minimum cash and cash equivalents amount. Threshold minimum cash and cash equivalents balance Threshold Minimum Cash And Cash Equivalents Amount Termination fees. Out-of-pocket fees and expenses. Termination fees Termination Fees Out-of-pocket fees and expenses Out Of Pocket Fees And Expenses Ownership percentage on equity of combined company upon closing of merger. Expected outstanding ownership percentage on common stock. Ownership percentage of combined company upon closing of merger Ownership Percentage On Equity Of Combined Company Upon Closing Of Merger Expected ownership percentage on common stock Expected Outstanding Ownership Percentage On Common Stock Realignment plan reduced the company's workforce, number of employees Restructuring And Related Cost Number Of Positions Eliminated Realignment plan reduced the company's workforce, percentage Restructuring And Related Cost Number Of Positions Eliminated Period Percent Realignment plan, one-time employee related severance expenses Severance Costs1 One-time payment received Proceeds From License Fees Received Summary of significant accounting policies. Summary of significant accounting policies. Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Loans Insured or Guaranteed by Government Authorities Loans Insured Or Guaranteed By Government Authorities [Axis] Loans Insured or Guaranteed by Government Authorities Loans Insured Or Guaranteed By Government Authorities [Domain] US Government Insured Loan Program [Member] Us Government Insured Loan Program [Member] Lender Name Line Of Credit Facility [Axis] Line of Credit Facility, Lender Line Of Credit Facility Lender [Domain] Medical technology enterprise consortium. Medical Technology Enterprise Consortium [Member] Medical Technology Enterprise Consortium [Member] Income Statement Location Income Statement Location [Axis] Income Statement Location Income Statement Location [Domain] General and Administrative Expense [Member] General And Administrative Expense [Member] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Number of operating segment Number Of Operating Segments Clinical trial discontinued as other income Other Income Uncertain tax positions Liability For Uncertain Tax Positions Current Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Measurement Frequency Fair Value By Measurement Frequency [Axis] Measurement Frequency Fair Value Measurement Frequency [Domain] Fair Value, Measurements, Recurring [Member] Fair Value Measurements Recurring [Member] Fair Value Hierarchy and NAV Fair Value By Fair Value Hierarchy Level [Axis] Fair Value Hierarchy and NAV Fair Value Measurements Fair Value Hierarchy [Domain] Level 1 [Member] Fair Value Inputs Level1 [Member] Level 2 [Member] Fair Value Inputs Level2 [Member] Level 3 [Member] Fair Value Inputs Level3 [Member] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Assets: Assets Fair Value Disclosure [Abstract] Cash and cash equivalents Cash And Cash Equivalents Fair Value Disclosure Total assets Assets Fair Value Disclosure Comprehensive income recognized Furniture and equipment estimated useful lives Property Plant And Equipment Useful Life Loss on disposition of furniture and equipment Gain Loss On Sale Of Property Plant Equipment Accrued project costs current. Accrued retention bonus current. Restructuring accrual (see Note 11) Restructuring Reserve Current Accounts payable Accounts Payable Current Professional fees Accrued Professional Fees Current Accrued project costs Accrued Project Costs Current Accrued retention bonus Accrued Retention Bonus Current Accrued vacation Accrued Vacation Current Accrued bonus Accrued Bonuses Current Other Other Accrued Liabilities Current Total accounts payable and accrued expenses Dividends common stock declared or paid Dividends Common Stock Cash Warrants vesting period. Number of class of warrants exercised. Class of warrant or right expiration date. Warrants outstanding Class Of Warrant Or Right Outstanding Number of warrants issued to purchase common stock Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Warrants exercise price per share Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Warrants vesting period Warrants Vesting Period Warrants expiration date Class Of Warrant Or Right Expiration Date Number of warrants exercised Number Of Class Of Warrants Exercised Temporary Equity Disclosure [Abstract] Preferred stock, shares authorized Preferred Stock Shares Authorized Preferred stock, par value Preferred Stock Par Or Stated Value Per Share Preferred stock, shares issued Preferred Stock Shares Issued Preferred stock, shares outstanding Preferred Stock Shares Outstanding Share based compensation arrangement by share based payment award number of additional shares authorized annual percentage. Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Plan Name Plan Name [Axis] Plan Name Plan Name [Domain] 2017 stock option and incentive plan. 2017 Stock Option and Incentive Plan [Member] Two Thousand Seventeen Stock Option And Incentive Plan [Member] Award Type Award Type [Axis] Award Type Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Stock Option [Member] Employee Stock Option [Member] Vesting Vesting [Axis] Vesting Vesting [Domain] One-year Anniversary [Member] Share Based Compensation Award Tranche One [Member] First Installment [Member] Share Based Compensation Award Tranche Two [Member] Second Installment [Member] Share Based Compensation Award Tranche Three [Member] Research and development [Member] Research And Development Expense [Member] Stock award. Stock Awards [Member] Stock Award [Member] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Common stock shares available for issuance Common Stock Capital Shares Reserved For Future Issuance Percentage applied to the outstanding shares as annual increase in number of shares authorized for issuance Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized Annual Percentage Shares issued for special retention grant. Share-based compensation arrangement by share-based payment award vesting date. Vesting period Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 Vesting percentage Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage Term of options to be granted Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period Shares issued for special retention grant Shares Issued For Special Retention Grant Option, vesting date Share Based Compensation Arrangement By Share Based Payment Award Vesting Date Options to purchase common stock, granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Shares, Outstanding at beginning balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Shares, Granted Shares, Exercised Shares, Expired/cancelled Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Shares, Outstanding at ending balance Shares, Expected to vest Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number Shares, Options exercisable Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Weighted Average Exercise Price, Outstanding at beginning balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Weighted Average Exercise Price, Granted Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Weighted Average Exercise Price, Exercised Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price Weighted Average Exercise Price, Expired/cancelled Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price Weighted Average Exercise Price, Outstanding at ending balance Weighted Average Exercise Price, Expected to vest Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price Weighted Average Exercise Price, Options exercisable Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Weighted Average Remaining Contractual Term, Outstanding Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Weighted Average Remaining Contractual Term, Expected to vest Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 Weighted Average Remaining Contractual Term, Options exercisable Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 Aggregate Intrinsic Value, Outstanding Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Aggregate Intrinsic Value, Expected to vest Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value Aggregate Intrinsic Value, Options exercisable Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 Unrecognized compensation cost related to stock options Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options Weighted average period expected to be recognized Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 Share-based compensation arrangement by share-based payment award, number of shares issued Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period Share-based compensation common stock fair market value Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 Disclosure Of Share Based Compensation Arrangements By Share Based Payment Award [Abstract] Disclosure Of Share Based Compensation Arrangements By Share Based Payment Award [Abstract] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] General and administrative [Member] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Stock-based compensation expense Weighted-average fair value of options granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Expected term (years) Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 Risk-free interest rate Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Expected volatility Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Expected dividend yield Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Current income tax expense or benefit Current Income Tax Expense Benefit Deferred income tax expense or benefit Deferred Income Tax Expense Benefit Net and comprehensive (loss) income attributable to common stockholders Net Income Loss Available To Common Stockholders Basic Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities, Name Antidilutive Securities Name [Domain] Options to Purchase Common Stock [Member] Warrants to Purchase Common Stock [Member] Warrant [Member] Weighted Average [Member] Weighted Average [Member] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Total amount of anti-dilutive securities excluded from computation of earnings per share Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Number of shares reserved for issuance annual increased percentage. Employee Stock Purchase Plan [Member] Employee Stock [Member] Maximum number of shares provided for issuance Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Percentage of annual increase in number of shares reserved for issuance Number Of Shares Reserved For Issuance Annual Increased Percentage Number of shares outstanding Maximum amount of milestone payments eligible to receive under license agreement. Maximum amount of sales milestone payments eligible to receive under license agreement. Maximum amount of milestone payments eligible to receive under license agreement Maximum Amount Of Milestone Payments Eligible To Receive Under License Agreement Maximum amount of sales milestone payments eligible to receive under license agreement Maximum Amount Of Sales Milestone Payments Eligible To Receive Under License Agreement Payment received from license agreement Revenue recognized Percentage of payments received by licensee. Percentage of payments received Percentage Of Payments Received By Licensee Schedule Of Restructuring And Related Costs [Table] Schedule Of Restructuring And Related Costs [Table] Restructuring Type Restructuring Cost And Reserve [Axis] Type of Restructuring Type Of Restructuring [Domain] Workforce Reduction [Member] Employee Severance [Member] Balance Sheet Location Balance Sheet Location [Axis] Balance Sheet Location Balance Sheet Location [Domain] Accounts Payable and Accrued Expenses [Member] Accounts Payable And Accrued Liabilities [Member] Restructuring Cost And Reserve [Line Items] Restructuring Cost And Reserve [Line Items] Realignment plan, number of employees reduced in workforce Realignment plan, number of employees reduced by percentage on workforce Realignment plan, employee severance expense Cash payments against severance liability Payments For Restructuring Remaining liability related to severance